| Hazard Information | Back Directory | [Uses]
STK17A/B-IN-1 (compound 9) is an orally active, potent, and selective STK17A/B inhibitor with an IC50 of 23 nM against STK17A. STK17A/B-IN-1 can be used for study of cancer[1]. | [References]
[1] Chaudhry S, et al. Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors. ACS Med Chem Lett. 2024;15(6):945-949. Published 2024 May 20. DOI:10.1021/acsmedchemlett.4c00125 |
|
|